Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Hideya Kato is active.

Publication


Featured researches published by Hideya Kato.


Interactive Cardiovascular and Thoracic Surgery | 2017

Flow-dynamics assessment of mitral-valve surgery by intraoperative vector flow mapping

Koichi Akiyama; Naotoshi Nakamura; Keiichi Itatani; Yoshifumi Naito; Mao Kinoshita; Masaru Shimizu; Saeko Hamaoka; Hideya Kato; Hiroaki Yasumoto; Yasufumi Nakajima; Toshiki Mizobe; Satoshi Numata; Hitoshi Yaku; Teiji Sawa

OBJECTIVES We assessed vortex patterns and energy loss in left ventricular flow in patients who underwent mitral valve repair or replacement with bioprosthetic valves. METHODS Vector flow mapping was performed before and after the procedure in 15 and 17 patients who underwent repair and replacement, respectively. The preprocedure mitral-septal angle was measured in all patients. Relationships between vortex patterns or energy loss change (ELC) and annuloplasty ring or bioprosthetic valve sizes or the effect of mitral leaflet resection in the repair group were statistically analysed. RESULTS Normal vortex patterns were observed in 13 and 1 patients who underwent repair and replacement, respectively. Abnormal vortex patterns were observed in 2 and 16 patients who underwent repair and replacement, respectively. ELC was significantly higher in the replacement group (196.6 ± 180.8) than in the repair group (71.9 ± 43.9). In the repair group, preoperative mitral-septal angles in patients with normal vortex patterns (79.2° ± 3.4°) were significantly larger than those in patients with abnormal vortex patterns (67.5° ± 3.5°). No significant differences were observed in the effects of annuloplasty ring and bioprosthetic valve sizes on vortex patterns and ELC, and in the effect of mitral valve resection (80.4 ± 56.3) and respect (without leaflet resection) (53.8 ± 28.4) on ELC in the repair group. CONCLUSIONS Mitral valve replacement alters the intraventricular vortex pattern and increases flow energy loss. A small mitral-septal angle is a risk factor for abnormal vortex patterns after mitral valve repair surgery.


Human Vaccines & Immunotherapeutics | 2016

The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa

Mao Kinoshita; Hideya Kato; Hiroaki Yasumoto; Masaru Shimizu; Saeko Hamaoka; Yoshifumi Naito; Koichi Akiyama; Kiyoshi Moriyama; Teiji Sawa

ABSTRACT The PcrV cap structure of the type III secretory apparatus of Pseudomonas aeruginosa is a vaccine target. Human immunoglobulin G (IgG) molecules extracted from sera containing high or low anti-PcrV titers were tested for their effects against P. aeruginosa pneumonia in a mouse model. Among 198 volunteers, we selected the top 10 high anti-PcrV titer sera and the bottom 10 low anti-PcrV titer sera and extracted the IgG fraction from each serum sample. First, we examined the effects of the IgG against virulent P. aeruginosa. A lethal dose of P. aeruginosa premixed with saline, low titer human IgG, high titer human IgG, or rabbit-derived polyclonal anti-PcrV IgG was intratracheally administered into the lungs of mice, and their survival and lung inflammation were evaluated for 24 h. The high anti-PcrV titer human IgG had a prophylactic effect. Next, the prophylactic effects of intravenous administration of extracted and pooled high or low anti-PcrV titer human IgG were examined. Here, prophylactic intravenous administration of pooled high anti-PcrV titer human IgG, which showed binding capacity to P. aeruginosa PcrV, was more effective than the administration of its low titer pooled equivalent, and the measured physiological and inflammatory parameters correlated with the anti-PcrV titer levels. This result indirectly implies that high anti-PcrV titers in blood can help to protect against virulent P. aeruginosa infections. In addition, the IgG fractions from such high titer sera have potential to be a source of specific intravenous immunoglobulin products for passive vaccination against virulent P. aeruginosa infections.


Toxins | 2016

Pseudomonas aeruginosa Type III Secretory Toxin ExoU and Its Predicted Homologs

Teiji Sawa; Saeko Hamaoka; Mao Kinoshita; Atsushi Kainuma; Yoshifumi Naito; Koichi Akiyama; Hideya Kato

Pseudomonas aeruginosa ExoU, a type III secretory toxin and major virulence factor with patatin-like phospholipase activity, is responsible for acute lung injury and sepsis in immunocompromised patients. Through use of a recently updated bacterial genome database, protein sequences predicted to be homologous to Ps. aeruginosa ExoU were identified in 17 other Pseudomonas species (Ps. fluorescens, Ps. lundensis, Ps. weihenstephanensis, Ps. marginalis, Ps. rhodesiae, Ps. synxantha, Ps. libanensis, Ps. extremaustralis, Ps. veronii, Ps. simiae, Ps. trivialis, Ps. tolaasii, Ps. orientalis, Ps. taetrolens, Ps. syringae, Ps. viridiflava, and Ps. cannabina) and 8 Gram-negative bacteria from three other genera (Photorhabdus, Aeromonas, and Paludibacterium). In the alignment of the predicted primary amino acid sequences used for the phylogenetic analyses, both highly conserved and nonconserved parts of the toxin were discovered among the various species. Further comparative studies of the predicted ExoU homologs should provide us with more detailed information about the unique characteristics of the Ps. aeruginosa ExoU toxin.


Journal of the American College of Cardiology | 2016

MITRAL VALVE REPLACEMENT IMPAIRS LEFT VENTRICULAR BLOOD FLOW

Koichi Akiyama; Keiichi Itatani; Mao Kinoshita; Masaru Shimizu; Saeko Hamaoka; Hideya Kato; Yoshifumi Naito; Yasufumi Nakajima; Satoshi Numata; Toshiki Mizobe; Hitoshi Yaku; Teiji Sawa

According to our experimental analysis, blood flow in left ventricle change after Mitral Valve Replacement. We attempted to investigate blood flow and energy loss (EL) in patients who were scheduled for mitral valve surgery using novel analysis software Vector Flow Mapping (VFM). Patients with


Journal of Clinical Monitoring and Computing | 2017

Effective evaluation of arterial pulse waveform analysis by two-dimensional stroke volume variation–stroke volume index plots

Teiji Sawa; Mao Kinoshita; Atsushi Kainuma; Koichi Akiyama; Yoshifumi Naito; Hideya Kato; Fumimasa Amaya; Keiji Shigemi

Arterial pulse waveform analysis (APWA) with a semi-invasive cardiac output monitoring device is popular in perioperative hemodynamic and fluid management. However, in APWA, evaluation of hemodynamic data is not well discussed. In this study, we analyzed how we visually interpret hemodynamic data, including stroke volume variation (SVV) and stroke volume (SV) derived from APWA. We performed arithmetic estimation of the SVV–SV relationship and applied measured values to this estimation. We then collected measured values in six anesthesia cases, including three liver transplantations and three other types of surgeries, to apply them to this SVV–SVI (stroke volume variation index) plot. Arithmetic analysis showed that the relationship between SVV and SV can be drawn as hyperbolic curves. Plotting SVV-SV values in the semi-logarithmic scale showed linear correlations, and the slopes of the linear regression lines theoretically represented average mean cardiac contractility. In clinical measurements in APWA, plotting SVV and SVI values in the linear scale and the semi-logarithmic scale showed the correlations represented by hyperbolic curves and linear regression lines. The plots approximately shifted on the rectangular hyperbolic curves, depending on blood loss and blood transfusion. Arithmetic estimation is close to real measurement of the SVV–SV interaction in hyperbolic curves. In APWA, using SVV as an index of preload and the cardiac index or SVI derived from arterial pressure-based cardiac output as an index of cardiac function, is likely to be appropriate for categorizing hemodynamic stages as a substitute for Forrester subsets.


Shock | 2016

Cellular Stress Responses and Monitored Cellular Activities.

Teiji Sawa; Yoshifumi Naito; Hideya Kato; Fumimasa Amaya

ABSTRACT To survive, organisms require mechanisms that enable them to sense changes in the outside environment, introduce necessary responses, and resist unfavorable distortion. Consequently, through evolutionary adaptation, cells have become equipped with the apparatus required to monitor their fundamental intracellular processes and the mechanisms needed to try to offset malfunction without receiving any direct signals from the outside environment. It has been shown recently that eukaryotic cells are equipped with a special mechanism that monitors their fundamental cellular functions and that some pathogenic proteobacteria can override this monitoring mechanism to cause harm. The monitored cellular activities involved in the stressed intracellular response have been researched extensively in Caenorhabditis elegans, where discovery of an association between key mitochondrial activities and innate immune responses was named “cellular associated detoxification and defenses (cSADD).” This cellular surveillance pathway (cSADD) oversees core cellular activities such as mitochondrial respiration and protein transport into mitochondria, detects xenobiotics and invading pathogens, and activates the endocrine pathways controlling behavior, detoxification, and immunity. The cSADD pathway is probably associated with cellular responses to stress in human inflammatory diseases. In the critical care field, the pathogenesis of lethal inflammatory syndromes (e.g., respiratory distress syndromes and sepsis) involves the disturbance of mitochondrial respiration leading to cell death. Up-to-date knowledge about monitored cellular activities and cSADD, especially focusing on mitochondrial involvement, can probably help fill a knowledge gap regarding the pathogenesis of lethal inflammatory syndromes in the critical care field.


JA Clinical Reports | 2017

Difficult tracheal intubation and post-extubation airway stenosis in an 11-month-old patient with unrecognized subglottic stenosis: a case report

Natsuko Ohsima; Fumimasa Amaya; Shunsuke Yamakita; Yoshinobu Nakayama; Hideya Kato; Yumi Muranishi; Toshiaki Numajiri; Teiji Sawa

BackgroundSubglottic stenosis can lead to life-threatening difficult tracheal intubation during general anesthesia. We report a case of difficult tracheal intubation in an 11-month-old female who had unrecognized subglottic stenosis.Case presentationThe patient was scheduled for elective correction of a right accessory auricle. She was suspected of having first and second branchial arch syndrome. Preoperative physical examination was normal. Anesthesia was induced uneventfully using sevoflurane. It was not possible to pass size 4.0, 3.5, or 3.0 cuffed endotracheal tubes due to an advanced subglottic lesion. Subsequent successful intubation was achieved using a 3.0 uncuffed tube. Stridor was audible after extubation, and the patient required several days’ treatment with dexamethasone to address respiratory distress.ConclusionsWe encountered unrecognized subglottic stenosis that led to difficult tracheal intubation and post-extubation airway stenosis.


BMC Cardiovascular Disorders | 2017

Vector flow mapping analysis of left ventricular energetic performance in healthy adult volunteers

Koichi Akiyama; Sachiko Maeda; Tasuku Matsuyama; Atsushi Kainuma; Maki Ishii; Yoshifumi Naito; Mao Kinoshita; Saeko Hamaoka; Hideya Kato; Yasufumi Nakajima; Naotoshi Nakamura; Keiichi Itatani; Teiji Sawa


Journal of Cardiothoracic and Vascular Anesthesia | 2017

Vector Flow Mapping and Impaired Left Ventricular Flow After the Alfieri Stitch

Koichi Akiyama; Keiichi Itatani; Yoshifumi Naito; Mao Kinoshita; Masaru Shimizu; Saeko Hamaoka; Hiroaki Yasumoto; Hideya Kato; Yasufumi Nakajima; Satoshi Numata; Hitoshi Yaku; Teiji Sawa


Journal of Infection and Chemotherapy | 2018

An outbreak of fluoroquinolone-resistant Pseudomonas aeruginosa ST357 harboring the exoU gene

Atsushi Kainuma; Kyoko Momiyama; Takeshi Kimura; Koichi Akiyama; Keita Inoue; Yoshifumi Naito; Mao Kinoshita; Masaru Shimizu; Hideya Kato; Nobuaki Shime; Naohisa Fujita; Teiji Sawa

Collaboration


Dive into the Hideya Kato's collaboration.

Top Co-Authors

Avatar

Teiji Sawa

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Yoshifumi Naito

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Koichi Akiyama

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Mao Kinoshita

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Saeko Hamaoka

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Atsushi Kainuma

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Keiichi Itatani

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Masaru Shimizu

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Yasufumi Nakajima

Kyoto Prefectural University of Medicine

View shared research outputs
Top Co-Authors

Avatar

Fumimasa Amaya

Kyoto Prefectural University of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge